Cargando…
Optical Coherence Tomography Predictors of Favorable Functional Response in Naïve Diabetic Macular Edema Eyes Treated with Dexamethasone Implants as a First-Line Agent
PURPOSE: To evaluate efficacy and safety of intravitreal dexamethasone 0.7 mg implant in treatment-naïve DME patients and to assess the utility of OCT structural biomarkers as predictors of functional response after treatment. METHODS: Thirty-nine eyes of 39 diabetic patients with center involving D...
Autores principales: | Meduri, Alessandro, Oliverio, Giovanni William, Trombetta, Luigi, Giordano, Marta, Inferrera, Leandro, Trombetta, Costantino John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012128/ https://www.ncbi.nlm.nih.gov/pubmed/33833870 http://dx.doi.org/10.1155/2021/6639418 |
Ejemplares similares
-
The Application of Structural Retinal Biomarkers to Evaluate the Effect of Intravitreal Ranibizumab and Dexamethasone Intravitreal Implant on Treatment of Diabetic Macular Edema
por: Ceravolo, Ida, et al.
Publicado: (2020) -
Differential response to intravitreal dexamethasone implant in naïve and previously treated diabetic macular edema eyes
por: Zarranz-Ventura, Javier, et al.
Publicado: (2020) -
Optical coherence tomography angiography analysis of microvascular abnormalities and vessel density in treatment-naïve eyes with diabetic macular edema
por: Braham, Imène Zhioua, et al.
Publicado: (2022) -
Cost-effectiveness of dexamethasone compared with aflibercept in naïve diabetic macular edema
por: Montes Rodríguez, Paula, et al.
Publicado: (2022) -
Optical coherence tomography and imaging biomarkers as outcome predictors in diabetic macular edema treated with dexamethasone implant
por: Chou, Hung-Da, et al.
Publicado: (2022)